Hyalex Orthopaedics

May 20, 2025

Hyalex Orthopaedics Receives FDA Approval of IDE Supplement, Expanding the Early Feasibility Study to a Pivotal Trial of Cutting-Edge Freestyle Knee Implant

Apr 22, 2024

Hyalex Orthopaedics Reports Treatment of First Patients with Novel HYALEX® Knee Cartilage System

Apr 15, 2024

Hyalex Orthopaedics Appoints Thomas Vail, M.D., as Chief Medical Officer and Names Adam Gridley to Board of Directors

Jan 31, 2024

Hyalex Orthopaedics to Present at Canaccord Genuity 2024 Musculoskeletal Conference